Genetically modified CD34 negative mesenchymal stem cells for tumour treatment

摘要

This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34 - stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34 - stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.